Abiopharma

News list

Nofi Michael 🟢 acquired 73.1K shares (2 derivative) of Edgewise Therapeutics, Inc. (EWTX) Transaction Date: Aug 12, 2026 | Filing ID: 000001

Full text

News bot Aug. 14, 2026, 8:55 p.m.
🔍 Nofi Michael (Executive)

Company: Edgewise Therapeutics, Inc. (EWTX)

Report Date: 2026-08-12
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 2
- Holdings reported: 0
- Total shares acquired: 73,125
Detailed Transactions and Holdings:
- Acquired 24,375 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-12 | Code: A | Expires: 2036-08-12 | equity_swap_involved: false | shares_owned_after: 24,375.00 | transaction_form_type: 4 | Footnotes: F1
- Acquired 48,750 shares of Stock Option (Right to Buy) (Derivative)
  Date: 2026-08-12 | Code: A | Expires: 2036-08-12 | equity_swap_involved: false | shares_owned_after: 48,750.00 | transaction_form_type: 4 | Footnotes: F2
Footnotes:
- F1: Restricted Stock Units ("RSUs") granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in four equal annual installments beginning on August 12, 2027.
- F2: 1/48th of the shares subject to the option vest each month beginning on September 12, 2026, subject to the Reporting Person continuing as a service provider through each vest date.